Patents by Inventor Soon Keng Cheong

Soon Keng Cheong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODUCTION OF THERAPEUTICS POTENTIAL MESENCHYMAL STEM CELLS
    Publication number: 20230325487
    Abstract: The present invention relates to production of therapeutic potential WJ-MSCs for clinical purposes. The WJ-MSCs cultured in optimal culture conditions for production of clinical grade WJ-MSCs wherein 4 different culture media which are Media A, Media B, Media C and Media D used to produce 4 types of WJ-MSCs with different therapeutic potential. The WJ-MSCs harvested from Media A has therapeutic potential related to immune, wound healing and cell migration and the WJ-MSCs harvested from Media B has therapeutic potential related to localization, cell proliferation and cell migration. Meanwhile, the WJ-MSCs harvested from Media C has therapeutic potential related to organ development and osteogenesis and the WJ-MSCs harvested from Media D has therapeutic potential related to tissue development, cell signaling and localization.
    Type: Application
    Filed: June 9, 2023
    Publication date: October 12, 2023
    Applicant: CRYOCORD SDN BHD
    Inventors: Ming Foong CHAI, Zhi Xin LEE, Vijayendran GOVINDASAMY, Soon Keng CHEONG, Khong Lek THEN
  • Cell-based composition and use thereof for treatment of diabetes and associated metabolic disorders and for amelioration of insulin resistance in pre-diabetes
    Patent number: 11052119
    Abstract: The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: July 6, 2021
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze-Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • PRODUCTION OF THERAPEUTICS POTENTIAL MESENCHYMAL STEM CELLS
    Publication number: 20200392454
    Abstract: The present invention relates to production of therapeutic potential WJ-MSCs for clinical purposes. The WJ-MSCs cultured in optimal culture conditions for production of clinical grade WJ-MSCs wherein 4 different culture media which are Media A, Media B, Media C and Media D used to produce 4 types of WJ-MSCs with different therapeutic potential. The WJ-MSCs harvested from Media A has therapeutic potential related to immune, wound healing and cell migration and the WJ-MSCs harvested from Media B has therapeutic potential related to localization, cell proliferation and cell migration. Meanwhile, the WJ-MSCs harvested from Media C has therapeutic potential related to organ development and osteogenesis and the WJ-MSCs harvested from Media D has therapeutic potential related to tissue development, cell signaling and localization.
    Type: Application
    Filed: October 15, 2019
    Publication date: December 17, 2020
    Inventors: Ming Foong Chai, Zhi Xin Lee, Vijayendran Govindasamy, Soon Keng Cheong, Khong Lek Then
  • Cell-based composition and use thereof for treatment of vernal keratoconjunctivitis
    Patent number: 10828332
    Abstract: A method for the treatment of vernal keratoconjunctivitis in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: November 10, 2020
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES
    Publication number: 20190209620
    Abstract: The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.
    Type: Application
    Filed: February 25, 2019
    Publication date: July 11, 2019
    Inventors: Bernard Sze-Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • Cell-based composition and use thereof for treatment of acute stroke
    Patent number: 10278993
    Abstract: A method for the treatment of acute stroke in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: May 7, 2019
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze-Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF PSORIASIS AND AUTOIMMUNE DISEASES
    Publication number: 20180028568
    Abstract: A method for the treatment of psoriasis or an autoimmune disease in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Application
    Filed: May 18, 2017
    Publication date: February 1, 2018
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF VERNAL KERATOCONJUNCTIVITIS
    Publication number: 20170354685
    Abstract: A method for the treatment of vernal keratoconjunctivitis in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Application
    Filed: May 18, 2017
    Publication date: December 14, 2017
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF MACULAR OEDEMA AND DEGENERATION
    Publication number: 20170354693
    Abstract: A method for the treatment of macular oedema and degeneration in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Application
    Filed: May 18, 2017
    Publication date: December 14, 2017
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF ACUTE STROKE
    Publication number: 20170340675
    Abstract: A method for the treatment of acute stroke in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 30, 2017
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES
    Publication number: 20170340676
    Abstract: The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 30, 2017
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong